Twenty Years of Therapeutic Leukocytapheresis in Newly Diagnosed Acute Myeloid Leukemia: Insights From A Single Center.

Abstract excerpt

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy, and 5%-20% of newly diagnosed patients present with hyperleukocytosis (HL). HL, most often defined as WBC > 100 000/μL, is a hematologic emergency associated with severe complications, early mortality, and poor prognosis, requiring immediate intervention. From November 2005 to September 2025, 65 newly diagnosed AML patients with HL underwent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aged
• Share to fms-Like Tyrosine Kinase 3